Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil

Affiliations

¹ Dermatology Department, Hospital Universitario Ramon y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain; Trichology Unit, Grupo de Dermatologia Pedro Jaen, Madrid, Spain. Electronic address: jjimenezc92@gmail.com.
² Dermatology Department, Hospital Universitario Ramon y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain; Trichology Unit, Grupo de Dermatologia Pedro Jaen, Madrid, Spain.
³ Dermatology Department, Hospital Universitario Ramon y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain.

Comment

Juan Jimenez-Cauhe et al. J Am Acad Dermatol. 2022 Dec.

. 2022 Dec;87(6):e235-e237.

doi: 10.1016/j.jaad.2022.06.1205. Epub 2022 Aug 13.

¹ Dermatology Department, Hospital Universitario Ramon y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain; Trichology Unit, Grupo de Dermatologia Pedro Jaen, Madrid, Spain. Electronic address: jjimenezc92@gmail.com.
² Dermatology Department, Hospital Universitario Ramon y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain; Trichology Unit, Grupo de Dermatologia Pedro Jaen, Madrid, Spain.
³ Dermatology Department, Hospital Universitario Ramon y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain.

No abstract available

Keywords: androgenetic alopecia; arterial hypertension; blood pressure; hair loss; hypotension.

Conflict of interest statement

Conflicts of interest None disclosed.

Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia.
Sanabria BD, Palmegiani E, Seron AF, Perdomo YC, Miot HA, Müller Ramos P. Sanabria BD, et al. J Am Acad Dermatol. 2023 Feb;88(2):436-437. doi: 10.1016/j.jaad.2022.05.026. Epub 2022 May 18. J Am Acad Dermatol. 2023. PMID: 35597386 No abstract available.